MedTrace Logo

Lab Evaluation of Novel Hearing Aid Coupling Method

NCT05377359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-03-28

Study results available
· View outcomes & findings →

Summary

Evaluation of different hearing aid coupling methods including two states of a novel coupling method and two traditional coupling methods.

Conditions

Interventions

DEVICE

Recordings of Hearing Aids with Open Domes

Receiver-in-the-Canal hearing aids will be used which are programmed to the participant's hearing loss and will be coupled to open domes. Recordings will be made of hearing aid output on a head and torso simulator and played back to participants over headphones.

DEVICE

Recordings of Hearing Aids with Closed Domes

Receiver-in-the-Canal hearing aids will be used which are programmed to the participant's hearing loss and will be coupled with closed domes. Recordings will be made of hearing aid output on a head and torso simulator and played back to participants over headphones.

DEVICE

Recordings of Hearing Aids with Novel State 1

Receiver-in-the-Canal hearing aids will be used which are programmed to the participant's hearing loss and will be coupled with the new coupling method in its first state. Recordings will be made of hearing aid output on a head and torso simulator and played back to participants over headphones.

DEVICE

Recordings of Hearing Aids with Novel State 2

Receiver-in-the-Canal hearing aids will be used which are programmed to the participant's hearing loss and will be coupled with the new coupling method in its second state. Recordings will be made of hearing aid output on a head and torso simulator and played back to participants over headphones.

Sponsors & Collaborators

  • Sonova Canada Inc.

    collaborator INDUSTRY

  • Western University, Canada

    collaborator OTHER

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Jinyu Qian, PhD · Sonova AG

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-07
Primary Completion
2023-11-20
Completion
2023-11-20

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377359 on ClinicalTrials.gov